Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-7547
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema ; volume:20 ; number:1 ; day:1 ; month:12 ; year:2022 ; pages:1-10 ; date:12.2022
Cost effectiveness and resource allocation ; 20, Heft 1 (1.12.2022), 1-10, 12.2022
- Klassifikation
-
Wirtschaft
- Urheber
-
Montes Rodríguez, Paula
Mateo Gabás, Javier
Esteban Floría, Olivia
Honrubia Grijalbo, Ana
Ascaso Puyuelo, Francisco J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12962-022-00401-z
- URN
-
urn:nbn:de:101:1-2023021021414172855421
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Montes Rodríguez, Paula
- Mateo Gabás, Javier
- Esteban Floría, Olivia
- Honrubia Grijalbo, Ana
- Ascaso Puyuelo, Francisco J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema